STOCK TITAN

Red Tree Group holds 3.17M shares in Bicara Therapeutics (BCAX) — 4.8%

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

BICARA THERAPEUTICS INC. owners Red Tree GP, LLC; Red Tree Venture Fund, L.P.; and Heath Lukatch filed an amendment to a Schedule 13G/A reporting beneficial ownership of 3,170,509 shares of common stock as of March 31, 2026. The filing reports this equals 4.8% of the class based on 65,467,187 shares outstanding as of March 24, 2026. The filing states Red Tree Fund I holds the shares directly, Red Tree GP I is the general partner, and Lukatch, as managing director, possesses shared voting and dispositive power over those shares.

Positive

  • None.

Negative

  • None.

Insights

Schedule 13G/A updates a passive/beneficial ownership disclosure for a sub‑5% holder.

The amendment documents that Red Tree Fund I holds 3,170,509 shares representing 4.8% of common stock as of the filing dates, and clarifies voting and dispositive authority flows through Red Tree GP I and Heath Lukatch.

Because the stake is below 5% and the filing is an ownership disclosure, its direct market impact is limited; subsequent changes in ownership or amendments would be the items to watch in later filings.

Shares beneficially owned 3,170,509 shares Beneficial ownership as of March 31, 2026
Percent of class 4.8% Percent based on 65,467,187 shares outstanding as of March 24, 2026
Shares outstanding used 65,467,187 shares Outstanding common stock as of March 24, 2026 (source: Form 10-K)
beneficially owned regulatory
"Row 9 of each Reporting Person's cover page to this /A sets forth the aggregate number"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared dispositive power regulatory
"Shared Dispositive Power 3,170,509.00"
Schedule 13G/A regulatory
"filed an amendment to a Schedule 13G/A reporting beneficial ownership"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does the Schedule 13G/A filed by BCAX disclose?

It reports beneficial ownership of 3,170,509 shares by Red Tree entities and Heath Lukatch. The filing states this was 4.8% of outstanding common stock based on 65,467,187 shares outstanding as of March 24, 2026 and ownership is reported as of March 31, 2026.

Who holds voting and disposition power over the BCAX shares?

Red Tree GP, LLC and Heath Lukatch are reported to possess power to direct voting and disposition of the shares held by Red Tree Fund I. The filing states Red Tree Fund I holds the shares directly and Red Tree GP I is its general partner.

Does this Schedule 13G/A indicate an acquisition or sale of BCAX stock?

No transaction is described in this amendment; it is an ownership disclosure. The filing reports existing beneficial ownership as of March 31, 2026 and does not state purchase or sale activity within the excerpt provided.

Why is the percentage ownership reported as 4.8% for BCAX?

The percentage is calculated using 65,467,187 shares outstanding reported in the company’s Form 10-K as of March 24, 2026. The filing states the 3,170,509 shares represent 4.8% of that outstanding total.





055477103

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Red Tree GP, LLC
Signature:/s/ Heath Lukatch, PhD
Name/Title:By Heath Lukatch, PhD, Managing Director
Date:05/08/2026
Red Tree Venture Fund, L.P.
Signature:/s/ Heath Lukatch, PhD
Name/Title:By Red Tree GP, LLC, its General Partner, By Heath Lukatch, PhD, Managing Director
Date:05/08/2026
Heath Lukatch
Signature:/s/ Heath Lukatch, PhD
Name/Title:Heath Lukatch, PhD
Date:05/08/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit A to the Reporting Persons' Schedule 13G filed with the SEC on September 26, 2024).